Doxacurium Chloride Articles
Abbott deals in brief
25 November 1999
WELLCOME'S US "TIDAL WAVE" REVERSING?
21 December 1992
NEW CHEMICAL ENTITIES UPDATE FOR 1991
10 February 1992
Showing 1-3 of 3 articles
- 1
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
